595 Type I interferon contributes to vasculopathy and accelerated fibrosis in systemic sclerosis
نویسندگان
چکیده
Systemic sclerosis (SSc) is one of the most devastating autoimmune diseases characterized by vasculopathy and fibrosis that affects both skin internal organs. IFN signature present in blood SSc patients. Polymorphisms regulatory genes IRF-4,5,7,8 STAT4 have been found to be associated with SSc. Despite these evidence, exact role remains poorly understood. We performed single-cell RNA sequencing on from patients diffuse SSc(dSSc), limited SSc(lSSc) normal controls. Higher type I interferon response was endothelium dSSc compared lSSc Gene expression endothelial-to-mesenchymal transition (EndoMT) also elevated These findings were confirmed another dataset. verified our protein level cohort higher disease progression. Interestingly, bleomycin-induced mouse model, administration IFNα AAV (adeno-associated virus) significantly accelerated EndoMT. In conclusion, data suggests a pathological fibrosis, which support blockade treatment.
منابع مشابه
Type I interferon in systemic autoimmune diseases
Th e hypothesis that type I interferon plays a central role in the pathogenesis of systemic lupus erythematosus (SLE) has gained growing support in recent years [1-4]. Th e early data from the 1970s demonstrating increased functional interferon activity in lupus patient sera have been confi rmed and extended using current technologies that permit detection of the broad gene expression program i...
متن کاملThe Role of Type 1 Interferon in Systemic Sclerosis
Systemic Sclerosis (Scleroderma, SSc) is an autoimmune disease characterized by vasculopathy, inflammation, and fibrosis that can lead to loss of organ function. Type I interferons (IFNs) are family of cytokines that mitigate the deleterious effects of viral and bacterial infections in the innate immunity system. Past several years, research efforts have been focused on the role of type I IFN a...
متن کاملFailed Degradation of JunB Contributes to Overproduction of Type I Collagen and Development of Dermal Fibrosis in Patients With Systemic Sclerosis
OBJECTIVE The excessive deposition of extracellular matrix, including type I collagen, is a key aspect in the pathogenesis of connective tissue diseases such as systemic sclerosis (SSc; scleroderma). To further our understanding of the mechanisms governing the dysregulation of type I collagen production in SSc, we investigated the role of the activator protein 1 (AP-1) family of transcription f...
متن کاملSystemic lupus erythematosus and the type I interferon system
Patients with systemic lupus erythematosus (SLE) have ongoing interferon-alpha (IFN-alpha) production and serum IFN-alpha levels are correlated with both disease activity and severity. Recent studies of patients with SLE have demonstrated the presence of endogenous IFN-alpha inducers in such individuals, consisting of small immune complexes (ICs) containing IgG and DNA. These ICs act specifical...
متن کاملStatins and the vasculopathy of systemic sclerosis: potential therapeutic agents?
It has been postulated that endothelial cell injury is the initiating event in the pathogenesis of systemic sclerosis, causing attraction, attachment, migration and infiltration of activated T-cells and subsequent production of cytokines and growth factors. As a result of the action of these cytokines and growth factors, chemoattraction of fibroblasts into the vessel wall and transdifferentiati...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Investigative Dermatology
سال: 2022
ISSN: ['1523-1747', '0022-202X']
DOI: https://doi.org/10.1016/j.jid.2022.09.612